{"id":20205,"date":"2024-05-28T14:48:23","date_gmt":"2024-05-28T14:48:23","guid":{"rendered":"https:\/\/organonpro.com\/es-es\/?post_type=news&#038;p=20205"},"modified":"2026-01-27T13:05:06","modified_gmt":"2026-01-27T13:05:06","slug":"effectiveness-of-cardioprevent-on-cardiovascular-disease","status":"publish","type":"news","link":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/","title":{"rendered":"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy"},"content":{"rendered":"\n<p><em>Dan Quansah and Kerri-Anne Mullen.&nbsp;<strong>Journal of the American College of Cardiology.&nbsp;<\/strong>2024 Apr, 83 (13_Supplement) 1725<\/em><\/p>\n\n\n\n<div style=\"height:40px\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><strong>Puntos clave:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Estudio que evalu\u00f3 la&nbsp;<strong>eficacia del programa posparto&nbsp;<em>CardioPrevent<\/em><\/strong><em>\u00ae<\/em>, una intervenci\u00f3n de&nbsp;<strong>cambio de conducta que pretende reducir la puntuaci\u00f3n en el riesgo cardiovascular<\/strong>, as\u00ed como modificar los factores de riesgo individual en mujeres con antecedentes de hipertensi\u00f3n en el embarazo.<\/li>\n\n\n\n<li>Se incluyeron 261 mujeres con antecedentes de hipertensi\u00f3n durante el embarazo a las 25 semanas posparto e inscritas en el programa.&nbsp;<strong>El programa se imparti\u00f3 por tel\u00e9fono<\/strong>&nbsp;y se completaron 17 sesiones de entrenamiento durante un a\u00f1o.&nbsp;<strong>Se ayudaba a las mujeres a realizar cambios de conducta<\/strong>&nbsp;(dejar de fumar, modificar la dieta, aumentar la actividad f\u00edsica) y junto con los m\u00e9dicos de atenci\u00f3n primaria,&nbsp;<strong>se optimizaron los tratamientos<\/strong>&nbsp;de los factores de riesgo.<\/li>\n\n\n\n<li>El 41% de las pacientes completaron el programa en el momento de la evaluaci\u00f3n. Se observ\u00f3 una&nbsp;<strong>reducci\u00f3n media de la puntuaci\u00f3n de riesgo cardiovascular<\/strong>,&nbsp;<strong>reducci\u00f3n<\/strong>&nbsp;significativa&nbsp;<strong>del peso y del per\u00edmetro de cintura<\/strong>. Adem\u00e1s, se observaron&nbsp;<strong>reducciones significativas de las tasas de depresi\u00f3n posparto, ansiedad y estr\u00e9s percibido<\/strong>. Se produjo un&nbsp;<strong>incremento de la actividad f\u00edsica moderada<\/strong>&nbsp;y en la proporci\u00f3n de mujeres que cumpl\u00edan con una&nbsp;<strong>alimentaci\u00f3n m\u00e1s saludable<\/strong>.<\/li>\n\n\n\n<li>Se concluy\u00f3 que&nbsp;<strong>se observaron reducciones significativas de los factores de riesgo de enfermedad cardiovascular a los 12 meses entre las participantes en el programa posparto&nbsp;<em>CardioPrevent<\/em>\u00ae.<\/strong><\/li>\n<\/ul>\n\n\n\n<div style=\"height:40px\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Enlace al art\u00edculo completo:&nbsp;<a href=\"https:\/\/www.jacc.org\/doi\/full\/10.1016\/S0735-1097%2824%2903715-X\">Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy<\/a><\/p>\n\n\n\n<div style=\"height:40px\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Este contenido estar\u00e1 disponible hasta el\u00a0<strong>28 de mayo de 2029<\/strong>.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dan Quansah and Kerri-Anne Mullen.&nbsp;Journal of the American College of Cardiology.&nbsp;2024 Apr, 83 (13_Supplement) 1725 Puntos clave: Enlace al art\u00edculo completo:&nbsp;Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy Este contenido estar\u00e1 disponible hasta el\u00a028 de mayo de 2029.\u00a0<\/p>\n","protected":false},"author":120,"featured_media":20212,"parent":0,"menu_order":0,"template":"","meta":{"_acf_changed":false},"tags":[],"news_categories":[215,214,210],"class_list":["post-20205","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-atencion-primaria","news_categories-cardiologia","news_categories-ginecologia-y-obstetricia"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.11 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy - Organon Pro - Espa\u00f1a<\/title>\n<meta name=\"description\" content=\"Descubre m\u00e1s sobre Cardioprevent, un programa de intervenci\u00f3n para prevenir el riesgo de ECV en mujeres con trastornos hipertensivos en el embarazo.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy\" \/>\n<meta property=\"og:description\" content=\"Descubre m\u00e1s sobre Cardioprevent, un programa de intervenci\u00f3n para prevenir el riesgo de ECV en mujeres con trastornos hipertensivos en el embarazo.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Organon Pro - Espa\u00f1a\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/OrganonandCo\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-27T13:05:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"676\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@OrganonLLC\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/\",\"url\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/\",\"name\":\"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy - Organon Pro - Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/organonpro.com\/es-es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg\",\"datePublished\":\"2024-05-28T14:48:23+00:00\",\"dateModified\":\"2026-01-27T13:05:06+00:00\",\"description\":\"Descubre m\u00e1s sobre Cardioprevent, un programa de intervenci\u00f3n para prevenir el riesgo de ECV en mujeres con trastornos hipertensivos en el embarazo.\",\"breadcrumb\":{\"@id\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#primaryimage\",\"url\":\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg\",\"contentUrl\":\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg\",\"width\":1200,\"height\":676},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/organonpro.com\/es-es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\/\/organonpro.com\/es-es\/news\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/organonpro.com\/es-es\/#website\",\"url\":\"https:\/\/organonpro.com\/es-es\/\",\"name\":\"Organon Pro - Espa\u00f1a\",\"description\":\"Organon Pro - Espa\u00f1a\",\"publisher\":{\"@id\":\"https:\/\/organonpro.com\/es-es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/organonpro.com\/es-es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/organonpro.com\/es-es\/#organization\",\"name\":\"Organon Pro - Espa\u00f1a\",\"url\":\"https:\/\/organonpro.com\/es-es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/organonpro.com\/es-es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2023\/08\/organon-pro-1.webp\",\"contentUrl\":\"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2023\/08\/organon-pro-1.webp\",\"width\":2269,\"height\":243,\"caption\":\"Organon Pro - Espa\u00f1a\"},\"image\":{\"@id\":\"https:\/\/organonpro.com\/es-es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/OrganonandCo\",\"https:\/\/x.com\/OrganonLLC\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy - Organon Pro - Espa\u00f1a","description":"Descubre m\u00e1s sobre Cardioprevent, un programa de intervenci\u00f3n para prevenir el riesgo de ECV en mujeres con trastornos hipertensivos en el embarazo.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/","og_locale":"en_US","og_type":"article","og_title":"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy","og_description":"Descubre m\u00e1s sobre Cardioprevent, un programa de intervenci\u00f3n para prevenir el riesgo de ECV en mujeres con trastornos hipertensivos en el embarazo.","og_url":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/","og_site_name":"Organon Pro - Espa\u00f1a","article_publisher":"https:\/\/www.facebook.com\/OrganonandCo","article_modified_time":"2026-01-27T13:05:06+00:00","og_image":[{"width":1200,"height":676,"url":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@OrganonLLC","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/","url":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/","name":"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy - Organon Pro - Espa\u00f1a","isPartOf":{"@id":"https:\/\/organonpro.com\/es-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#primaryimage"},"image":{"@id":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg","datePublished":"2024-05-28T14:48:23+00:00","dateModified":"2026-01-27T13:05:06+00:00","description":"Descubre m\u00e1s sobre Cardioprevent, un programa de intervenci\u00f3n para prevenir el riesgo de ECV en mujeres con trastornos hipertensivos en el embarazo.","breadcrumb":{"@id":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#primaryimage","url":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg","contentUrl":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2024\/05\/cardioprevent-thumbnail.jpg","width":1200,"height":676},{"@type":"BreadcrumbList","@id":"https:\/\/organonpro.com\/es-es\/news\/effectiveness-of-cardioprevent-on-cardiovascular-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/organonpro.com\/es-es\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/organonpro.com\/es-es\/news\/"},{"@type":"ListItem","position":3,"name":"Effectiveness of Cardioprevent\u00ae postpartum program on cardiovascular disease risk scores and individual risk factor changes in women with prior hypertensive disorders of pregnancy"}]},{"@type":"WebSite","@id":"https:\/\/organonpro.com\/es-es\/#website","url":"https:\/\/organonpro.com\/es-es\/","name":"Organon Pro - Espa\u00f1a","description":"Organon Pro - Espa\u00f1a","publisher":{"@id":"https:\/\/organonpro.com\/es-es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/organonpro.com\/es-es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/organonpro.com\/es-es\/#organization","name":"Organon Pro - Espa\u00f1a","url":"https:\/\/organonpro.com\/es-es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/organonpro.com\/es-es\/#\/schema\/logo\/image\/","url":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2023\/08\/organon-pro-1.webp","contentUrl":"https:\/\/organonpro.com\/es-es\/wp-content\/uploads\/sites\/11\/2023\/08\/organon-pro-1.webp","width":2269,"height":243,"caption":"Organon Pro - Espa\u00f1a"},"image":{"@id":"https:\/\/organonpro.com\/es-es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/OrganonandCo","https:\/\/x.com\/OrganonLLC"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/news\/20205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/users\/120"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/media\/20212"}],"wp:attachment":[{"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/media?parent=20205"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/tags?post=20205"},{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/organonpro.com\/es-es\/wp-json\/wp\/v2\/news_categories?post=20205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}